News Releases

News Releases

August 8, 2019
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
LONDON and NEW YORK, Aug. 08, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the pricing of an underwritten public offering of 3,200,000 of its ordinary shares at a public offering price of $23.50 per
May 10, 2019
MeiraGTx Appoints Nicole Seligman to Board of Directors
LONDON and NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the appointment of Nicole Seligman to its Board of Directors. Ms. Seligman is an accomplished leader with extensive executive,
March 26, 2019
MeiraGTx Reports Full Year 2018 Financial Results
LONDON and NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results for the fourth quarter and full year ended December 31, 2018 . “2018 was a transformative year for MeiraGTx
March 6, 2019
MeiraGTx to Present at the Barclays Global Healthcare Conference
LONDON and NEW YORK, March 06, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes , Ph.D., president and chief executive officer, will present at the Barclays Global Healthcare Conference
Displaying 1 - 10 of 15